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Abstract
Phase transitions in closed vesicles. i.e., microenvironments defined by the size of the vesicle, its contents, and permeability of its
membrane are becoming increasingly important in several scientific disciplines including catalysis, growth of small crystals, cell function
studies, and drug delivery. The membrane composed from lipid bilayer is in general impermeable to ions and larger hydrophilic ions. Ion
transport can be regulated by ionophores while permeation of neutral and weakly hydrophobic molecules can be controlled by
concentration gradients. Some weak acids or bases, however, can be transported through the membrane due to various gradients, such as
electrical, ionic (pH) or specific salt (chemical potential) gradients. Upon permeation of appropriate species and reaction with the
encapsulated species precipitation may occur in the vesicle interior. Alternatively, these molecules can also associate with the leaflets of
the bilayer according to the transmembrane potential. Efficient liposomal therapeutics require high drug to lipid ratios and drug molecules
should have, especially when associated with long circulating liposomes, low leakage rates. In this article we present very efficient
encapsulation of two drugs via their intraliposomal precipitation, characterize the state of encapsulated drug within the liposome and try to
fit the experimental data with a recently developed theoretical model. Nice agreement between a model which is based on chemical
potential equilibration of membrane permeable species with experimental data was observed. The high loading efficiencies, however, are
only necessary but not sufficient condition for effective therapies. If adequate drug retention within liposomes, especially in the case of
long-circulating ones, is not achieved, the therapeutic index decreases substantially. Anticancer drug doxorubicin precipitates in the
liposome interior in a form of gel with low solubility product and practically does not leak out in blood circulation in the scale of days.
With an antibiotic, ciprofloxacin, the high loading efficacy and test tube stability is not reproduced in in vitro plasma leakage assays and
in vivo, We believe that the reasons are higher solubility product of precipitated drug in the liposome, larger fraction of neutral molecules
due closer p K values of the drug with the pH conditions in the solutions and high membrane permeability of this molecule. High
resolution cryoEM shows that encapsulated anticancer agent doxorubicin is precipitated in the form of bundles of parallel fibers while
antibiotic ciprofloxacin shows globular precipitate. Doxorubicin gelation also causes the change of vesicle shape.
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1. Introduction
Vesicles are becoming, in addition to their medical
applications, increasingly important systems to study vari-
ous physico-chemical, catalytic, and biological phenomena
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[1]. As a model system in biology they can serve as a
two-dimensional solid or fluid matrix to study membrane
proteins, biomineralization, cellular transport and interI in-
tracellular traffic. Recently spontaneous phase transition in
the aqueous phase within vesicles were observed due to
enhanced accumulation of amphiphilic weak bases into
vesicles by the force of transmembrane chemical potential
gradient. Precipitation in vesicle interior can be also in-
duced by inclusion of various ionophores in the bilayer
and can offer a convenient system to study the mechanism
of various crystallizations, biomineralizations, tissue calci-
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fication or in the preparation of colloid-sized microcrys-
tals. Of course, it is also extremely important in drug
delivery where a stable drug encapsulation is a necessary
condition in most applications [1-4].
One of the main obstacles in the development of liposo-
mal therapeuticals is their poor loading capacity, especially
in the predominantly used small vesicles « 100 nm), and
stability of the encapsulated drug [1,2]. There are several
techniques, such as preparation of liposomes at very high
lipid concentrations where they encapsulate most of the
space, which enable high loading efficiencies but in most
cases they are hampered by poor entrapment stability, i.e.,
quick release of the encapsulated molecules, and problems
with down sizing of vesicles without releasing drug. The
problem is still amplified by the use of long circulating
liposomes [5,6] which circulate in patients up to a week, in
contrast to few (tens of) minutes of most conventional
liposome formulations. In addition, upon infusion into
human body liposomes can be diluted several loo-fold
which makes all the comparisons with most in vitro tests,
such as plasma induced leakage. and toxicity/efficacy
studies in mice, where dilutions are approx. 5-fold abso-
lutely unrealistic [2,3] because due to simple solution
thermodynamics this results in quick reequilibration which
can release most of the encapsulated or membrane
bound/embedded molecules within microseconds.
In a preliminary report we have presented a concept of
drug precipitation in the liposome interior and via an
example of drug gelation showed its strongly improved
stability of encapsulation [7]. In this article we would like
to further characterize the gel formed in liposomes as well
as describe another system in which the encapsulated drug
is precipitated, as we believe, in a crystalline state. In both
cases we used the ammonium sulfate gradient method [8,9]
for the loading of vesicles. Concentration driven accumula-
tion of anticancer drug doxorubicin in the liposome inte-
rior resulted in the formation of a gel while antibiotic
ciprofloxacin precipitated in similar conditions. The stabil-
ity of encapsulation of this drug was found to be lower
than the one exhibited by doxorubicin. Several possible
reasons will be given.
A theoretical model which was introduced elsewhere in
detail [10] was employed to explain the loading of these
two drugs. Very good agreement with experimental data
was found.
2. Experimental
2./. Liposome preparation
In order to be able to follow in vivo stability of the
encapsulated drug we have used in most studies sterically
stabilized liposomes with the following composition'2000 •
PEG-DSPE/HSPC/Chol = 1:3:1 (w/w) (PEG, poly-
ethylene glycol; DSPE, distearoyl phosphatidylethanol-
amine; HSPC, hydrogenated soy phosphatidylcholine;
Chol, cholesterol). Upon hydration of dry lipid film in 250
mM ammonium sulfate. pH 5.5 (unbuffered), (or ethanol
injection followed by diafiltrationz'dialysis) multilamellar
liposomes were extrudedyrnicrofluidized to a final size of
80-90 nm [1,5]. External ammonium sulfate was replaced
with 10% sucrose, pH 5.5 (unbuffered) by dialysis.
2.2. Loading of liposomes
These liposomes at 50 ILmoljml were mixed with
doxorubicin HCI (DOX) solution at 6 mgyrnl in isotonic
sucrose equivolumetrically. After 1/2 to I h incubation at
6Q°C preparations were cooled to room temperature. If
necessary, free drug was removed by ion exchange or gel
chromatography. The final preparation was diluted to 20
mM total lipid and doxorubicin concentration of 2 mg/ml.
For active loading of ciprofloxacin (CIP) the above
liposomes were mixed with several different concentrg,
tions of ciprofloxacin HCI solutions, as indicated in the
figure caption, in 10% sucrose. The concentration of lipo-
somes used during the incubation was approx. 50 mM total
lipid and the pH of the unbuffered drug solution ranged
between 4-4.5. The percent of drug loading was deter_
mined spectrophotometrically after separating the free-form
from liposome encapsulated-drug by using a Sephadex
G-50 column. For large scale preparations. free drug
molecules were removed by diafiltration using a hol1o w
fiber cartridge (Amicon). Some samples were prepared in
glycine buffer at pH 3.5 without noticeable differences in
loading and stability.
2.3. Liposome leakage assays
Test tube stability assay simply consists of measUring
the fraction of nonencapsulated drug by separating it from
liposomal drug on a desalting column (Pierce I X 5 Cm)
for DOX or G-50 column (I X 30 ern) for CIP and meaSUr_
ing drug spectrophotometrically in total volume (free drug)
and encapsulated drug in the void volume after lysis of
liposomes. Dilution induced leakage (DIL) assay consist
of diluting liposomes to a specified concentration. (no ~
mallya lOO-fold dilution), incubation at 37°C for specifiefd
time (normally I and 24 h) and repeating the encapsulatio
efficiency assay as described above. Plasma induced leak~
age (PIL) is equivalent to OIL with exception that 50~
plasma is normally used as a dilution medium. 0
2.4. Small angle X-ray scattering
For SAXS measurements liposomes were pelleted
5 at240000 rpm (10 X g) for 12 h and the pellet was an
Iyzed. In a control experiment, prolonged rocking (I daa)
of the pellet resulted in vesicles with equivalent si Y
distribution as before the centrifugation. IISPC/Chol lipze
somes did not disperse after equivalent treatment. 0-
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2.5. Solid phases
DOX-S04 and Dox-Cl gel: a concentrated sodium sul-
fate/ chloride solution was added to DOX solution in
water to a final concentration [Dox] = 10-30 mgyrnl, and
[S04,Cl] = 5-250 mM. Heterogeneous gel - a mixture of
solid and fluid phases - was heated to 60-70°C. It melted
and a homogeneous solution upon cooling solidified into a
homogeneous solid. In contrast to sulfate gels which were
orange-red and opaque, Cl-gels were dark red and trans-
parent.
CIP-S04 precipitate: to an aqueous solution of
3. Theory of loading
ciprofloxacin HCI concentrated sodium sulfate was added.
The mixture was centrifuged at 3000 rpm for 1/2 hand
the precipitate was used for SAXS and EM studies. In
contrast to doxorubicin gels this precipitate was birefrin-
gent and consisted of very long and thin needles, as
observed in optical microscope.
Liposomes as well as model gels were studied by
several different physico-chemical methods. Cryoelectron
microscopy and small angle X-ray scattering measure-
ments were performed as described previously [7,11,12].
Negative stain microscopy was performed by using uranyl
acetate.
In contrast to the pH gradient method which can be approximated by Hendersohn-Hasselbalch equation [10,13-16] the
loading in the case of ammonium sulfate gradient is a much more complex process.
The rigorous theory of loading of drugs into liposomes, which takes into account all acid/base equilibria in both
interacting compartments as well as possible binding of particular species onto inner/outer bilayer surface and the
formation of the precipitate inside the liposomes, was described elsewhere [10]. Briefly, two basic assumptions were applied
to develop the theoretical treatment of interacting inner and outer solutions in liposome systems. Firstly, concentration
gradients of permeable species represent a driving force for permeation of molecules resulting in their concentration
equilibration on both sides of the bilayer. Secondly, the permeation of all charged species is assumed to be negligible. This
enabled the development of a set of Master Equations, derived from chemical equilibria equations of each species, mass and
charge balance, with which concentration of any species inside or outside of the liposomes can be calculated. The
equilibrium state in the liposome suspension, i.e., the concentrations of all species, including charged and noncharged forms
of drug molecules in either compartment, can be described by three nonlinear x, y and RP dependant equations, where x
and yare concentrations of protons inside and outside of liposomes, respectively, and RP is the ratio between amounts of
immobilized and dissolved drug. These equations take into account all possible initial chemical parameters in both
compartments (outer/inner volume ratio, concentration of acids/bases/salts/buffers, their acidity constants (pKa values)
and chemical composition as well as solubility product of the precipitated form of the drug or binding constants of
membrane adsorbed drugs). One can solve this system of equations by the Newton-Raphson method and within a particular
parameter range calculate values like loading efficiency (percentage of drug molecules inside the liposomes), inner and
outer pH, concentration of particular species in either compartment, exchanged amount ratio (influx/efflux), etc. Therefore,
the effect of each of the parameters on the behavior of liposome systems can be studied in the form of different diagrams in
which loading efficiencies, internal or external pH, etc. are calculated for different values and combinations of all of these
parameters. The mathematical formalism is explained in details in a paper by Ceh and Lasic, in which theoretical curves,
such as loading efficiency, inner or outer pH as a function of liposome, drug, and buffer concentrations, pK of the drug and
similar, for various sets of parameters are shown [10].
Assuming the activity coefficients are equal to I (dilute solutions), the particular examples of loading of the CIP and
DOX into the liposomes can be defined by the following three equations (for details see Ref. [10]). Master Equation
describing the state of the outer solution is in this particular system, as obtained from the general equation [10]:
(1)
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The state of the inner solution is described by an analogous Master Equation:
(2)
and for the solubility product one gets
L, - [ K;' (1+ Kll/x +K'l/x')( I +:') + (;)(1 + Kll/y +K'l/l) l'
~~ ~ l ) (1 + Kl\/x+K21/ X2 ) ~~ K42 )\X c3 - - clRP (Y) (3)2 K~I(1+Kl\/x+KllK21/X2)(I+RP)+\-:; (1 + Kll/y + K IlK211Y2 ) K42 +x
Here K; is the ratio of nonencapsulated versus the encapsulated volume, c, is the initial concentration of the drug (CIP,
DOX), c2 the starting concentration of the glycine (only in some cases of CIP loading; in the case of DOX loading C2= 0),
both of them in the outer solution, C3 is the starting concentration of the ammonium sulfate in the liposomes and a the
portion of hydrochloric acid with regards to glycine (for adjustment of the outer pH, in our case 7.5%), The corresponding
pK,j values are: for DOX pK ll = 8.2, pKI2 = 10.2; for CIP, pK II = 6.0, pKI2= 8.8, for glycine, pK2\ = 2.34, pK22 = 9.6,
for ammonia, pK31 = 9.26, and for sulfuric acid, pK42= 1.92. The solubility product for (CIPH)2S04 and for (DOXH)2S0 4
were found to be 8.0' 10-6 and 1.1 . 10- 7, respectively. Due to the fact that corresponding pHJpH o (inner/outer) pairs,
calculated from the Eqs. (1)-(3) in both of the treated systems, are much lower than all the pKa values, except the first one
of glycine and second from the sulfuric acid, the Eqs. (1)-(3) may be reduced to considerably simpler expressions Eqs.
(4)-(6). Therefore, for the outer compartment one can obtain the following equation:
1 I 1
C 1 ( X) + 2c3 ( X ) + c2 I + K / + Y - aC 2 - c1= 0
K- 1 - (I+RP)+1 - +K 21 Y
y Y Y y
(4)
where a represents the fraction of buffered glycine (i.e., to lower the pH of solution one has to add HCI, in our case
a = 3/40 = 0.075). Then, for the inner compartment:
(5)
and finally for the solubility product:
(6)
Using these equations, as indicated in the discussion and figure captions, we have calculated the loading efficiencies of
doxorubin and ciprofloxacin for experimental conditions used in their preparation.
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4. Results and discussion
Fig. I shows cryoelectron micrographs of doxorubicin
and ciprofloxacin loaded in sterically stabilized liposomes,
respectively. In the first case one can see the periodic
structure of fibrilar gel while in the second one some
globular precipitates/crystallites can be observed in the
liposome interior.
Although in vitro gel samples could not achieve as high
DOX concentrations as in liposome interior (> 0.2 M,
which is more than 5-fold aqueous solubility due to the
active pumping mechanism), the gel structures look rather
similar. Detailed studies (Fig. Za) of Dox-sulfate gel have
shown fibers with diameters of 28 A interwoven into
bundles. Local symmetry appeared to be the same as in
liposomes (Fig. la). The same periodicity was observed
also by negative stain (Fig. 2b). Fibers were also observed
in chloride-gel, but in contrast to the sulfate gel the fibers
are not aligned. Cl-gel seems to be composed of a random
three-dimensional network of thin, separated fibers and
this can explain its transparency (Fig. 2c).
Equivalent periodicity of 28 Ain the DOX-sulfate gel
in vitro as well as in liposomes was also observed by
SAXS [7]. It seems that the periodicity reflects the distance
between aligned fibers within a bundle and is proportional
to the thickness of the fibers. It is possible that fibers
represent stacks of doxorubicin molecules connected by
monofbi dentate sulfate bridges. Such structures are com-
mon in liquid crystals. The fibers may be bound together
by H-bonds (see b~low). A weak helical twist with a pitch
of approx. 1000 A can be observed. Chloride gel and
dense doxorubicin solution (at 20 mgyrnl, self-aggregation
starts at < 0.5 mg/rnl) did not yield any reflections. In
contrast to doxorubicin containing liposomes, the ones
loaded with ciprofloxacin do not show any X-ray reflec-
tions. This may indicate either amorphous nature of the
precipitate or that the size of the crystalline particles is too
small to give constructive diffraction. Macroscopic obser-
vation of CIP crystallization in optical microscope showed
very quick growth of very long (millimeters), thin (mi-
crometers) and rigid fibers. Because doxorubicin, in con-
trast, gave nonbirefringent (i.e., optically isotropic) gels we
believe that precipitate is in crystalline form. From EM
observations we can understand optical isotropy by a
network of too thin fibers to interact with the wavelength
of visible light.
The microscopic similarity between test tube precipitate
and intraliposome precipitate was not reproduced in the
ciprofloxacin liposomes. Fig. 2d shows test tube precipi-
tate.
In the test tube investigations sulfate and chloride gels
exhibited well defined phase transition solid-fluid as could
be observed by naked eye in a temperature bath. The
temperature of the fluidization/solidification depends on
the concentrations of both ions, pH and was in the range
from 40-70°C. Higher concentrations of either component
resulted in higher transition temperature. Phase transition
exhibited large hysteresis (10-20°C, depending on the
cooling rate) upon cooling. DSC measurements with Perkin
Elmer model 7 DSC however, did not show any phase
transition. This is possibly due to very weak H bonds
which hold the gel network together. No phase transition
was observed also in the liposome sample. The absence of
the bilayer phase transition can be explained by high
amount of cholesterol. Visual observations as well as
simple qualitative mechanical tests showed that gel was
the hardest around pH 5.5-6.
The origin of peculiar vesicle shape change upon encap-
sulation of doxorubicin is still not clear. It is possible that
the new morphology is due to the osmotic imbalance upon
precipitation or simply due to mechanical interaction of gel
fibers with the membranes. Equivalent lipid composition
and efficient loading of ciprofloxacin at unchanged shapes,
however, may indicate the second possibility.
We should note that doxorubicin formulations using
ammonium sulfate gradient are much more stable with
respect to the leakage of drug than the ones with pH
gradient in liposomes with similar/equivalent membrane
composition [7,8,17,18]. The reasons are the formation of a
stable precipitate, pH in the Iiposomes (not only lipids and
therefore their permeability barrier properties and the sta-
bility of the entrapment but also gel is the most stable in
the pH region between 5 and 6), and the differences in the
membrane permeability which can be scaled down to the
difference between escape rate of H+ and sol- (ap-
proximately seven orders of magnitude difference [I)).
Also, the reservoir of protons is much larger in the case of
the ammonium sulfate gradient method.
High membrane permeability of antibiotic ciprofloxacin
was inferred from the loading experiments in which the
drug could be loaded into liposomes already at 30°C (Fig.
3). In contrast, doxorubicin can be effectively loaded only
above 55°C using the same lipid composition. Larger
values of solubility product, or other kind of drug associa-
tion within vesicle, coupled with high drug permeability
can therefore result in relatively quick drug release from
vesicles. Also, pK values of ciprotloxacin are closer to the
values of pH in the system and the fraction of neutral
molecules is higher.
Another possible mechanism of the drug leakage may
be simple rupture of liposome membrane by the growing
crystals. In optical microscope ciprotloxacin crystals
showed thin, elongated, needle-like structures. Biomineral-
ization studies of crystal growth inside vesicles have also
shown that phosphate and apatite crystals can pierce the
vesicle membrane upon controlled growth and induce con-
tents leakage [19]. Cryoelectron microscopy images, how-
ever, do not support this picture.
Fig. 4 shows the leakage of ciprotloxacin in in vitro
assay. While percent of the drug encapsulation in in vitro
stability assays does not change in several months, the
dilution with plasma (PIL assay) shows significant leak-
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At present. however. we have developed only a general
model for loadin g of the dru gs into preform ed liposomes
by the influence of various gradie nts.
Eac h of the co rresponding origi nal Master Eqs. ( I)- (2)
and (4)-(5) represents a descr ipt ion of parti cul ar case of
the so-called bidi rectional exc hange loadi ng [10] or. in our
case. ammonium sulfate gradient loadin g [7- 9]. In Figs . 5
and 6 the loading efficie nc ies ( K~ I c;"'i<le / C~lUl . ' UrI ) at
d ifferent K v values for DOX as well as for CIP liposome
systems are give n, ca lculated from the followi ng equa tion:
age . Co rresponding experiment with doxorubi cin causes
minimal leakage. Whil e plasma ci rculation half-lives for
doxorubicin encapsulated in long-circul ating liposomes in
rats and mice are aro und 22 h [20.21], half of the injec ted
dose of ciprotloxacin encapsulated in sterically stabilized
liposome . as measured by an HPLC assay. is taken up in
1.5 h. At present we do not know if this is caused by
leakage or liposome uptake. PIL data and othe r ex peri-
ences with terically stabilized liposornes, such as indepen-
dence of blood circulation time on the marker . see m to
point to the first possibilit y. Before we co ntinue with the
theoretical model we should point out that the model
presented below can be in principle also used to study the
leakage rate. Detailed composition of the exte rnal phase
would have to be taken into acco unt.
(I + KII/x+ KII KI 2/x 2) ( 1+ RP )
(I + K II/ x+ K 21 / x2) ( 1 + RP ) +Kv(; )A (7)
f ig. I. (A ) Cryoelec tron micrograph of Stealth doxorubi cin I' , (8) C -I " . ' .,
. rposomes, ryoe cctron nncrograph of Stealth ciprofloxacin liposomes. (C) Ncgaliv' 'l"
micrograph of Stea lth doxorubicin liposom cs. C s urn
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Fig. I (co ntinued).
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Fig. 2. (A) ryoelectron micrograph of doxoroh ici n·sulfale gel. (B ) I ega tive stain micrograph of doxorohici n·,ulfale gel. (C) cgativc slain micro graph of
doxorub i in chloride gel. (0) ega tive Main microgra ph of ciproflo xa in sulfate gel.
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100 nm
Fig. 2 (continued) .
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Fig. 3. Loading of ciprofloxaci n at differen t temperature, as described in expe rimental pan .
(where A = I + K i l l )' + K I I K 12h ,2 ) or. for reasons men-
tioned above. from its simplified form:
The experimental loading efficiency measurements arc also
shown. As an illustrative example and to draw comparison
with liposome system where no precipitate formation is
assumed. in each of the figures one ( K v dependent) curve
(B) is drawn for the case of RP= 0 (i.c.. excluding the
possibility of the precipitate formation). with K , = 30 for
DOX loading and K v = 20 for IP loading (meaning that
liposorncs encapsulate 3.2 and 4.8% of the aqueous vol-
ume. respectively). It is interesting to compare the course
of these curves with those where precipitate formation is
considered (point of inflection). In both figures it is easy to
see a general trend. i.e.. diminishing loading efficiency
with increasing drug concentration at constant lipid con-
centration as well as with increasing ratio of outerl inner
volumes. K , . Also. in both cases the course of the curves
which implies the precipitate formation (A. the presence of
the point of inflection) drastically differ from that where
precipitation is not assumed. The calculated values of
loading efficiency arc. depending on drug concentration,
10- 80% higher in the cases where precipitate is assumed
to be formed. Surprisingly. thc theoretically calculated
loading efficiencies arc rather insensitive to Lp-changes
(there are hardly changes within a unit or two on a present
p Lp scale: calculations not shown).
In the case of DOX the agreement between theoretical
and measured values is more than satisfying. Even more,
nice agreement between experimental data and theory con-
firms, in addition to EM and SAXS data. precipitate
formation inside the liposomcs. At given K v values (in -
verse to lipid concentration and size of the vesicles) and
drug concentrations the calculations show that most of IP
(over 80%) and DOX (over 98%) is in the precipitated
form. The calculated pH values of inncr and outer solution
after loading moderately and strongly depend on concen-
tration and K v (Figs. 7 and 8). Because measurements of
(X)( 1+ RP )
( I +RI' )+ K,(S)a = - - - - - - ....,-.-.-
Release of Clpro from S-clpro In Buffer and Rat Plasma
(Bat ch 931-12)
70
8 0
£! 50
Q.
o 40
~
... 3 0
'0
~ 20
1 0
- ....- control
-o- plasma43
o +-----+- - --4--_ _ -< -<
o 2
Hour al 37'C
Fig. 4. Liposo~al ciprofloxac in (S.-C1PRO I was diluted I()()" fold in rat plasma or 5'J1 dextrose solution (co ntro l) 10 a tinal concentration of approx . 50
~g/ml. ~e diluted samples were incuba ted at 37°C for various time . Free and encapsulated c ipro floxacin we re separated hy a Hie-Gel A-5111 co lumn and
concentratio n of the dru g was determined by HPLC.
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Fig. 6. Percentage of loaded drug as a function of ciprofloxacin HCI
concentration. Experiment: liposomes were incubated with drug at differ-
ent concentrations. After loading the encapsulation efficiency was mea-
sured spectrophotometrically at 278 nm after separation of Iiposomal and
free drug on 0-25 columns. Curve B indicates loading without precipitate
formation. Fit parameters: internal concentration of ammonium sulfate,
c =250 roM, Kv =20 (A/B), 25 (1), 30 <2>, 35 <3>, 40 (4), and 50 (5).
Experimental points were determined for Kv = 20 (ellipsoids) and 25
(rectangles).
Fig. 5. Percentage of loaded drug as a function of doxorubicin HCI
concentration. Experimental points show% of loading for given drug and
Iiposomes concentrations. After loading the encapsulation efficiency was
measured spectrophotometrically at 480 nm after separation of Iiposomal
and free drug by Pierce desalting columns. Curve B indicates loading
without precipitate formation. Fit parameters: internal concentration of
ammonium sulfate, C" 155 roM, and intemalliposome volume: Kv = 30
(A/B), 43 (I; experimental points-rectangles), 60 (2, ellipsoids), 100 (3,
triangles), 200 (4, ellipsoids).
2.5
4.0
II)
i::
a-~ 3.5
-:::J
o
'ii 3.0
c
.5
2.0 .J,...:;- --.-_---.__~__-----l
o 10 20 30 40 50 60
Concentration of CIP.HCI (mM)
4.5 ~:----------------.
Fig. 8. Internal and external values of pH as a function of ciprofloxacin
HCI concentration for different values of internal volume of liposomes.
Internal concentration of ammonium sulfate, c ... 250 roM, Kv = 20
(A/B), 25 (2), 30 <3>, 35 (4), 40 (5), and 50 (6).
due to relatively lower accuracy in CIP measurements,
including its leakage (considerable differences between the
measurements at the same conditions are observed here).
Excess of ammonium sulfate in liposomes was often
used to explain enhanced stability due to its large reservoir
of protons. From the above equations we should add that
the influence of co-ion, i.e., large excess of sulfate ions
strongly reduces the solubility of doxorubicin. This is
similar to a salting out precipitation caused by a co-ion
present at large excess.
Very encouraging pre-clinical and clinical trials with
doxorubicin encapsulated in Stealth liposomes show that in
addition to long circulation times and liposome ability to
extravasate at sites of trauma, stable drug encapsulation is
necessary for high therapeutic efficacy. Similar liposomes
with higher drug leakage rates were found to be therapeuti-
cally much less effective [22].
The rather quick leakage of ciprofloxacin teaches us
Fig. 7. Internal and external values of pH as a function of doxorubicin
HCI concentration for different values of internal volume of Iiposomes.
Internal concentration of ammonium sulfate, c = 155 roM, K v = 30
(A/B), 43 (1), 60 (2), 100 <3>, 200 (4).
10 20 30 40 50 60
Concentration of CIP.HCI (mM)
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~ 80%
e
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w
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e
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pH in such systems are very demanding and rather inaccu-
rate we believe that these results shed additional light on
the loading process.
The agreement between theoretical and experimental
values in the case of CIP loading is, in comparison to
DOX, a little less satisfying, but nevertheless, the forma-
tion of precipitate can also be confirmed (Fig. 6). The
loading efficiencies at higher concentrations fit in lower
K values (K l::; 20-30), those under 15 mM in higherv y
values (K y l::; 30-50). The differences mentioned may be
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about the complexity of the problem. Excellent test tube
stability was not reproduced in in vitro assays and there-
fore we recommend rigorous in vitro tests, such as stability
upon large (up to \OOO-foid if sensitivity of analysis
allows) dilutions, with buffer and with plasma at several
temperatures to assess suitability of particular formulation
for in vivo studies.
In order to expect stable encapsulation we believe,
solubility product should be low, uncharged drug should
have low octanoljbuffer partition coefficient and low
membrane permeability at physiological conditions and
counterion should be present in excess and have very low
membrane permeability. Several other means to improve
drug encapsulation, such as formation of complex, binding
to the membrane or encapsulated (polyhons and molecular
traps, can be envisaged [I, \0]. However, our results indi-
cate that all the approaches for drug retention in the
liposomes must be carefully considered and evaluated in
vitro in order to avoid unpleasant surprises in the efficacy
studies. Of course, similar analysis must be done also for
hydrophobic and membrane bound drugs. In these cases
thermodynamic equilibria establish even faster and upon
large dilution all the membrane embedded or associated
drug can immediately pop out from the Iiposome and
infusion of Iiposomal drug actually resembles infusion of
empty liposomes and free drug.
Another possibility to improve drug retention are the
so-called gelosomes [23, I]. These are liposomes with en-
capsulated polymerizable agent which can upon poly-
merization stabilize Iiposome as well as its cargo, i.e.,
reduces its leakage. Liposomes are formed at temperature
above the solid-fluid phase transition of the medium,
preferentially at high lipid concentration (to increase the
encapsulated fraction of aqueous medium), and upon dilu-
tion and lowering of the temperature gelatine polymerizes
in the liposome interior. Experimental conditions, i.e.,
gelatine concentration, can be tailored to induce the gela-
tion at particular temperature what may offer the develop-
ment of temperature sensitive release system. Of course,
the diffusion constant of the drug in hydrogel should be
measured to check if significant reduction is achieved.
These phase transitions were driven by concentration
difference of membrane permeable species. Similarly,
crystallizations due to selective membrane transfer of par-
ticular ions upon incorporation of specific ionophores can
be induced. Such systems may offer preparation of minute
crystals or amorphous solids and can further shed light on
the formation of inorganic colloidal particles as well as
explain the growth of bones, calcification of tissues and
similar.
In conclusion, we have presented dynamic two com-
partment system in which chemical potential gradients
coupled with asymmetric specific reactions can effectively
concentrate particular molecules in the liposome interior to
so high concentrations that these substances precipitate
inside.
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